Drug Approvals

Lynkuet (Elinzanetant) A Promising New Treatment for Menopausal Hot Flashes

Lynkuet (Elinzanetant) A Promising New Treatment for Menopausal Hot Flashes

Many women going through menopause have hot flashes and night sweats that make it hard to sleep and feel comfortable. Until recently, most treatments used hormones, which aren’t right for everyone. A new medicine called Lynkuet (generic name elinzanetant) offers a non-hormonal option that helps reduce these symptoms. It was approved by the FDA in 2025 after several...

Xolremdi: A New Treatment for WHIM Syndrome Approved on April 26, 2024

Xolremdi: A New Treatment for WHIM Syndrome Approved on April 26, 2024

What is it prescribed for? XOLREMDI is indicated in patients 12 years of age and older with WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis) to increase the number of circulating mature neutrophils and lymphocytes. What is the name of the drug and what does it do? Xolremdi (pronounced zohl-REM-dee), (generic name: mavorixafor), is a...

Yorvipath: Managing Hypoparathyroidism with Ease Approved on August 9, 2024

Yorvipath: Managing Hypoparathyroidism with Ease Approved on August 9, 2024

What is the name of the drug and what does it do? Yorvipath (pronounced YOR-vih-path), generic name palopegteriparatide, is a medication used to treat adults with hypoparathyroidism, a condition where the parathyroid glands don’t produce enough parathyroid hormone (PTH). This hormone is essential for regulating calcium and phosphate levels in the body. Yorvipath...